Preclinical combination chemotherapy of nedaplatin with gemcitabine against gemcitabine-refractory human lung cancer

Cancer Letters

Volumn 182, Issue 1, 2002, Pages 61-68

  Takeda, Yukihiro ^a   Wada, Tohru ^a   Nishitani, Yoshinori ^a   Matsumoto, Mitsunobu ^a   Hojo, Kanji ^a   Maekawa, Ryuji ^a   Yoshioka, Takayuki ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Combination chemotherapy; Gemcitabine; Gemcitabine resistance; Lung cancer; Nedaplatin

Indexed keywords

CYTARABINE; GEMCITABINE; IRINOTECAN; MITOMYCIN C; NEDAPLATIN; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; LUNG CARCINOMA; MONOTHERAPY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INDUCTION; R FACTOR;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATP-BINDING CASSETTE TRANSPORTERS; CYTARABINE; DEOXYCYTIDINE; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; ORGANOPLATINUM COMPOUNDS; P-GLYCOPROTEIN; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0037043592     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00066-6     Document Type: Article

References (35)

1. Synthesis of (glycolato-O,O′) diammineplatinum (II) and its related complexes
2. Effect of treatment schedule on antitumor activity of glycolato-O,O′ diammineplatinum (II), a new platinum derivative: Comparison with cis-diamminedichloroplatinum (II)
3. Anti-tumor activity of 254-S, a platinum complex, in rodents
4. Nephrotoxicity of a new platinum compound, 254-S, evaluated with rat kidney cortical slices
5. Phase II study of (glycolato-O,O′) diammineplatinum (II), a novel platinum complex, in the treatment of non-small-cell lung cancer
6. An early phase II study of cis-diammine glycolato platinum, 254-S, for head and neck cancers
7. Phase II study of cis-diammine (glycolato) platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer and transitional-cell carcinoma of urinary tract
8. Synergy of combination of nedaplatin with etoposide in murine and human lung carcinoma
9. Sequence-dependent antitumor efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumor model
10. Combination chemotherapy with nedaplatin and cyclophosphamide in human ovarian cancer model
11. Sequence-dependent antitumor efficacy of combination chemotherapy with nedaplatin, a newly developed platinum, and paclitaxel
12. Preclinical in vivo activity of 2′,2′-difluorodeoxycytidine (Gemcitabine) against human head and neck cancer
13. Gemcitabine. A cytidine analogue active against solid tumors
14. PhaseII study of gemcitabine in advanced colorectal adenocarcinoma
15. Phase II trial of gemcitabine (2′,2′-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas
16. Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: A phase II study
17. Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group
18. Phase II study of gemcitabine (2′,2′-difluorodeoxycytidine) in previously treated ovarian cancer patients
19. Clinical experience with gemcitabine in pancreatic carcinoma
20. Synergistic interaction between cisplatin and gemcitabine in vitro
21. Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines
22. Phase I study of gemcitabine and cisplatin in non-small cell lung cancer
23. Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: A phase II study
24. Combination therapy with gemcitabine in non-small cell lung cancer
25. Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)
26. Cisplatin and gemcitabine in non-small-cell lung cancer
27. Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin-etoposide in the treatment of locally advanced or metasitatic non-small-cell lung cancer
28. Gemcitabine and carboplatin: An update of Phase I and II studies in non-small cell lung cancer
29. Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer
30. Non-P-glycoprotein-mediated multidrug-resistant human KB cells selected in medium containing adriamycin, cepharanthin, and mezerein
31. Adult T-cell leukemia cells over-express the multidrug-resistance-protein (MRP) and lung-resintance-protein (LRP) genes
32. Some statistical methods useful in circulation research
33. New tables for multiple comparisons with a control
34. Development and molecular characterization of a 2′,2′-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780
35. Overexpression of ribonucleotide reductase as a mechanism of resistance to 2,2-difluorodeoxycytidine in the human KB cancer cell line